Trial intelligence / Profile preview

Bioequivalence of Tramadol Hydrochloride 100 mg Extended-Release Tablets in Healthy Thai Volunteers

TCTR20170118003Completed

Sponsor
Government Pharmaceutical Organization
Start
May 2017
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of tramadol in pain (2 arms), sponsored by Government Pharmaceutical Organization. Primary endpoint: Bioequivalence based on pharmacokinetic parameters. Started May 2017; status: completed.

02

Drugs

tramadol
03

Conditions

pain

Beyond the preview

Go deeper on TCTR20170118003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20170118003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call